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Abstract
In mitochondria ATP synthesis is not perfectly coupled to oxygen consumption due to proton leak across the
mitochondrial inner membrane. Quantitative studies have shown that proton leak contributes toV25% of the resting oxygen
consumption of mammals. Proton leak plays a role in accounting for differences in basal metabolic rate. Thyroid studies,
body mass studies, phylogenic studies and obesity studies have all shown that increased mass-specific metabolic rate is linked
to increased mitochondrial proton leak. The mechanism of the proton leak is unclear. Evidence suggests that proton leak
occurs by a non-specific diffusion process across the mitochondrial inner membrane. However, the high degree of sequence
homology of the recently cloned uncoupling proteins UCP 2 and UCP 3 to brown adipose tissue UCP 1, and their extensive
tissue distribution, suggest that these novel uncoupling proteins play a role in proton leak. Early indications from
reconstitution experiments and several in vitro expression studies suggest that the novel uncoupling proteins uncouple
mitochondria. Furthermore, mice overexpressing UCP 3 certainly show a phenotype consistent with increased metabolism.
The evidence for a role for these novel UCPs in mitochondrial proton leak is reviewed. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
In mammals, basal metabolism can conveniently
and accurately be determined by measuring oxygen
consumption rate under resting conditions [1]. Mito-
chondria are the major site of oxygen consumption
in mammals. The free energy released from the com-
bustion of substrates is converted to ATP. However,
some of that energy is converted to heat due to an
ine⁄ciency in the coupling of ATP synthesis to oxy-
gen consumption, a phenomenon known as mito-
chondrial proton leak. Quantitative studies have
shown that proton leak contributes to V25% of
the resting oxygen consumption of the rat. Proton
leak is also a determinant in accounting for di¡er-
ences in basal metabolic rate. Thyroid studies, body
mass studies, phylogenic studies and obesity studies
have all shown that increased mass-speci¢c metabolic
rate is linked to increased mitochondrial proton leak
(for reviews see [2^4]).
There is also an emerging literature suggesting that
uncoupling protein 2 (UCP 2) and uncoupling pro-
tein 3 (UCP 3) are important determinants of basal
metabolism. The novel homologues of a known mi-
tochondrial uncoupling protein (UCP 1), from
brown adipose tissue (BAT), have chromosomal lo-
cations close to markers of basal metabolic rate. Fur-
thermore, mutations in these proteins have been
linked to reduced metabolic rates in humans. Tissue
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mRNA for UCP 2 and UCP 3 expression studies
also suggest an adaptive role in energy metabolism,
with UCP 3 in particular being associated with con-
ditions that increase fatty acid mobilisation and ox-
idation, however few data exist correlating amounts
of UCP 2 and UCP 3 protein with function (for re-
views see [5^8]).
2. Oxidative phosphorylation and di¡usion-based
proton leak
Oxidative phosphorylation is the process by which
synthesis of ATP, by the ATP synthase of mitochon-
dria, is coupled to oxygen consumption by mitochon-
dria via the proton electrochemical gradient (vp) (re-
viewed in [9]). As electrons pass along the electron
transport chain, vp is generated as a result of the
translocation of protons from the mitochondrial ma-
trix to the cytosol across the mitochondrial inner
membrane. The ultimate acceptor of the electrons
is oxygen, which is converted to water at cytochrome
oxidase. vp is used to drive ATP synthesis. However,
in the absence of ATP synthesis (or in the presence
of oligomycin, an Fo ATP synthase channel inhibi-
tor), mitochondria still consume oxygen (state 4) de-
veloping a maximal vp of about 220 mV. The result-
ing curve is non-Ohmic and has (in the opinion of
this author) been correctly interpreted as represent-
ing oxygen consumption due to leakage of protons
across the mitochondrial inner membrane [2]. Proton
leak shows a non-Ohmic relationship with its driving
force, vp (Fig. 1), in mitochondria from all sources
thus far studied. Proton leak is not an artefact of
mitochondrial isolation. A similar non-Ohmic rela-
tionship between oxygen consumption due to proton
leak and vp can be observed in mitochondria in situ
in cells and tissues. Furthermore the contribution of
proton leak to the oxygen consumption in intact sys-
tems can be quanti¢ed. Proton leak accounts for
V20% of the oxygen consumption of cells, tissues
and indeed a whole animal. It is now generally ac-
cepted that mitochondrial proton leak or natural
proton leak is a signi¢cant contributor to basal me-
tabolism (for reviews [2^4]).
Further evidence for the importance of proton
leak as a determinant of basal metabolism comes
from studies on factors that e¡ect basal metabolism.
Thyroid status is a major determinant of basal me-
tabolism. Animals made hyperthyroid have a higher
metabolic rate than sham treated euthyroid animals,
and part of this increase is due to an increased mi-
tochondrial proton leak. Animals made hypothyroid
have a lower metabolic rate than euthyroids and mi-
tochondrial proton leak is decreased [10^13]. In ad-
dition, an interspecies comparison of proton leak was
made from mammals of di¡ering body mass [14,15].
It has long been known that the mass-speci¢c meta-
bolic rate of larger animals is greater than that of
smaller animals. In accordance with these di¡erences
in mass-speci¢c metabolic rate, it was observed that
proton leak was greater in mitochondria, both iso-
lated and in situ, from smaller mammals compared
to larger mammals. In a further consolidation of the
evidence for the importance of proton leak to basal
metabolism, reptiles of similar mass to mammals
have lower metabolic rates and lower mitochondrial
Fig. 1. Kinetics of the proton leak for liver mitochondria from
lean, obese mice. Mouse liver mitochondria (3.3 mg) were incu-
bated in a Clark-type oxygen electrode at 37‡C in 3.3 ml of me-
dium containing 120 mM KCl, 1 mM EGTA, 1 Wg/mg oligo-
mycin, nigericin (100 pmol/mg) and 5 mM HEPES adjusted to
pH 7.2 with KOH. Five sequential addition of methytriphenyl-
phosphonium iodide (TPMPI3) were made to the chamber of
the Clark-type oxygen electrode to facilitate calibration of the
TPMP-electrode giving a ¢nal concentration of 5 WM. 7.5 mM
succinate (K salt, pH 7.2) was added to initiate oxygen con-
sumption; titration of the membrane potential was with 0^10
mM malonate (K salt, pH 7.2), shows proton leak kinetics for
mitochondria from lean (E) and obese (b) mice.
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proton leak [16]. And in obese (ob/ob) mice, where
lean mass-speci¢c metabolic rate is greater than that
of lean animals [17], proton leak has been shown to
be increased (Fig. 1) [18,19].
The mechanism behind the ‘basal proton leak’ is
not that clear. Di¡erences in proton leak rate (at any
given membrane potential) correlate with di¡erences
in mitochondrial inner membrane surface area as
evidenced from thyroid status, mammal/reptile com-
parisons and body mass studies [2,16,20]. The non-
Ohmic nature of the proton leak kinetics is charac-
teristic of di¡usion processes [21,22] and certainly if
proton leak occurs by delocalised di¡usion, than in-
ner membrane surface area di¡erences could account
for the majority of di¡erences in proton leak rate
observed. Di¡erences in proton leak rate have also
been correlated with di¡erences in mitochondrial in-
ner membrane phospholipid fatty acid composition.
In general, phospholipids from leakier membranes
have more polyunsaturated fatty acids [16,20,23,24].
However there is no signi¢cant di¡erence in perme-
ability of deproteinised phospholipid unilamellar
vesicles made from mitochondria in which proton
leak di¡erences do occur [24], suggesting a role for
proteins in basal proton leak.
However, one does not have to invoke speci¢c
uncoupling proteins to account for this basal proton
leak. Mitochondria from yeast have proton leak but
do not have inner membrane proteins that have high
homology to the UCPs [4,25]. Mitochondria in and
from parenchyma cells of the liver are leaky to pro-
tons [10,15] but do not have inner membrane pro-
teins that have high homology to the UCPs [26].
Di¡erences in basal proton leak may be due in part
to interaction of di¡erent phospholipid fatty acids
with membrane proteins, in general, as would be
suggested by the work of Clandinin et al. [27]. Mea-
sured di¡erences in basal proton leak rates have also
been attributed to di¡erences in the amount of free
non-esteri¢ed fatty acids associated with mitochon-
drial preparations. Incorporation of defatted bovine
serum albumin to mop up fatty acids in the prepa-
ration has been shown e⁄cacious in minimising the
uncoupling e¡ect of free fatty acids [12,13,28].
Fig. 2. Multiple sequence alignment of rat UCP 1, UCP 2 and UCP 3. The diagram shows alignment of UCP 1 (accession number
M11814), UCP 2 (accession number AF039033) and UCP 3 (accession number AB 006614) from rat. The tripartite signature motif
common to mitochondrial anion transporters, is highlighted in bold. The ¢gure also highlights the consensus sequence EGPAAFFKG
in UCP 1 and its equivalent (EGPAAFYKG) in UCP 2 and UCP 3 (EGPTAFYKGF) at the C-terminal end of the proteins. Also in
bold is Arg-277 of rat UCP 1, equivalently positioned Arg-279 of rat UCP 2 and Arg-278 of rat UCP 3. The contiguous sequence
EGPAAFFKG and the Arg-276 (Arg-277 in rat) of mouse UCP 1 have been implicated in purine nucleotide binding.
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3. Mitochondrial function in brown adipose tissue
The non-linear relationship between oxygen con-
sumption due to proton leak and vp has been ob-
served for mitochondria from a variety of tissues. In
mitochondria from brown adipose tissue (BAT) there
is a proton leak catalysed by uncoupling protein 1
(UCP 1) (originally called thermogenin or uncou-
pling protein) that is superimposed upon this basal
proton leak. BAT is innervated by the sympathetic
nervous system and noradrenaline causes the expres-
sion of UCP 1 concomitant with an increase in
brown adipose tissue mitochondrial volume density.
Expression of UCP 1, and an increase in BAT mito-
chondrial volume density, occur in all new-born in-
fants and animals and is an adaptive feature for heat
generation. BAT persists in adult rodents and is trig-
gered in a cold environment and preparation/reawak-
ening from torpor. BAT is the source of non-shiver-
ing thermogenesis (for reviews see [8,29^31]).
When isolated, mitochondria from active BAT are
uncoupled. Thus they have a high oxygen consump-
tion rate and a low or negligible vp. If measurable,
an Ohmic relationship is observed between leak rate
and vp. Addition of purine nucleotides recouple iso-
lated BAT mitochondria and state 4 oxygen con-
sumption occurs to a similar extent as mitochondria
from tissue not expressing UCP 1. In the presence of
purine nucleotides high vp values are attainable and
oxygen consumption rates due to proton leak display
a non-Ohmic relationship with vp. Purine nucleo-
tides bind to UCP 1 and prevent proton (and chlo-
ride) translocation. Some of the amino acids known
to be involved in purine nucleotide binding in UCP 1
have been identi¢ed from chemical modi¢cation,
photoa⁄nity labelling and site-directed mutagenesis
studies [30,32^34]. The purine nucleotide binding site
of UCP 1 is located on the cytosolic side towards the
C-terminus of the protein (Fig. 2). The contiguous
sequence EGPAAFFKG, associated with the sixth
putative helix, has been reported to be involved in
purine nucleotide binding in mouse (and rat) UCP 1.
Similar contiguous sequences EGPRAFYKG and
EGPTAFYKG are found at a similar location in
UCP 2 and UCP 3 from rat. In addition, site-di-
rected mutagenesis studies have shown that three ar-
ginines equivalent to Arg-84 (helix 2), Arg-183 (helix
4) and Arg-277 (helix 6) in the rat UCP 1 sequence
are essential for purine nucleotide binding. Arginines
at similar locations are found in UCP 2 and UCP 3.
It is therefore possible that UCP 2 and UCP 3 could
bind purine nucleotides and that proton (and chlo-
ride) translocation by them may be purine nucleotide
sensitive.
UCP 1 also has a requirement for free fatty acids
that are thought to directly interact with the pro-
tein. However, there is evidence that UCP 1 activity
exists but is submaximal in the absence of free
fatty acids [6,31]. Mitochondria containing UCP 1
or reconstituted native UCP 1 can also catalyse
transport of chloride ions, a function that is purine
nucleotide sensitive and fatty acid insensitive. The
mechanism by which free fatty acids are involved
in the UCP 1 uncoupling process is still a matter
of investigation with two basic models being pro-
posed: (i) the fatty acid £ip-£op model and (ii) the
model where fatty acid acts as a prosthetic group to
UCP 1 (for reviews see [31^35]). The possibility
therefore exists that the novel uncoupling proteins,
UCP 2 and UCP 3, may also require fatty acids for
(maximal) activity.
4. The novel mitochondrial UCPs
The recent cloning of membrane proteins UCP 2
[36,37] and UCP 3 [38,39], which have V56% ho-
mology to UCP 1 and V73% homology to each
other, has generated a fervent if not as yet very fruit-
ful avenue of research. UCP 1 is a member of a
family of mitochondrial anion transporters [40] and
is found exclusively in BAT. UCP 2 is most widely
distributed being present at high mRNA levels in
spleen, lung intestine, white adipose tissue (WAT)
and uterus, with prominent expression in kidney,
testes, uterus, BAT, brain, heart, and detectable ex-
pression in skeletal muscle and liver [36,37]. The
UCP 2 mRNA in the liver is thought to be attribut-
able to the Kup¡er cells and not the parenchyma
cells [26].
UCP 3 transcript on the other hand is detectable
in BAT and in rat skeletal muscle with particular
prominence in tensor fascia latae (fast-twitch, glyco-
lytic), tibialis anterior (fast-twitch, oxidative/glyco-
lytic) and gastrocnemius (mixed) muscles and to a
lower level in the soleus muscle (slow-twitch, oxida-
BBABIO 44999 19-2-01
R.K. Porter / Biochimica et Biophysica Acta 1504 (2001) 120^127 123
tive) [38,39]. UCP 3 also exists in two forms: long
(L) which is the full-length protein, and short (S)
which lacks V30 amino acids from its C-terminus.
A mitochondrial subcellular localisation is strongly
suggested by the primary sequences of UCP 2 and
UCP 3. In particular, the tripartite recurrent motif
that is characteristic of mitochondrial anion trans-
port protein is present in UCP 2 and UCP 3 (Fig.
2). In addition their size and molecular weight are
similar to those of mitochondrial anion transporters
[40]. Immunodetection, functional assays and puri¢-
cation, combined with UCP 1 knockout studies have
¢rmly established UCP 1 as a mitochondrial inner
membrane protein [6,32,41]. The data also suggest
that the novel UCPs have mitochondrial localisation.
In the case of UCP 2, immunodetection has been
performed using UCP 2 peptide antibodies, antibod-
ies to whole UCP 2 expressed in Escherichia coli or
antiserum to whole UCP 1. UCP 2 was ¢rst detected
immunohistochemically by Larrouy et al. [26] using a
highly sensitive antiserum against UCP 1. A V33
kDa signal was observed in the mitochondrial frac-
tion of Kup¡er cells which do not express UCP 1 or
UCP 3 but express UCP 2 mRNA, suggesting that
the antigen was UCP 2. Cadenas et al. [28] found
that peptide antibodies to the 20 N-terminus of hu-
man or rat UCP 2 could not detect an appropriate
molecular weight band in rat muscle or mitochondria
isolated from skeletal muscle, however antigen could
be detected in WAT with reference to a HEK293/
UCP 2 expression system. Chavin et al. [18] detect
mitochondrial associated UCP 2 protein using immu-
nohistochemistry in liver slices of ob/ob mice with no
detection in liver of non-obese mice using primary
antisera to a UCP 2 peptide. Horvath et al. [42]
used rabbit anti-UCP 2 antibody and found that
UCP 2 was associated with mitochondria (immuno-
histochemistry) of neurons, predominantly in axons
and axon terminals in divergent hypothalamic and
limbic sites.
With regard to immunodetection of UCP 3, anti-
sera to UCP 1 and peptide antibodies to UCP 3 have
been successful. Cadenas et al. [28] have shown that
peptide antibodies to a 14 amino acid human UCP 3
peptide detect a 32 kDa protein in rat hind limb
skeletal muscle rats. In addition there is a 2-fold in-
crease in UCP 3 protein in the whole muscle and
mitochondria isolated from that muscle upon starva-
tion. Their UCP 3 peptide antibody was also speci¢c
for UCP 3, it not being able to detected UCP 2.
Interestingly, antisera to whole UCP 1 failed to de-
tect UCP 2/3 in BAT mitochondria in UCP 1 ablated
mice, despite the increased UCP 2/3 mRNA levels
[43].
The limited amount of Western blot data on UCP
2 and UCP 3 in non-transgenic tissues (and in iso-
lated mitochondria from those tissues) could be due
to poor antibodies or poor technique. However, in
cases where UCP 2 or UCP 3 is detected, the
amounts fall way short of those found for UCP 1
in BAT. It just might be that amounts of novel UCP
proteins expressed constitutively in skeletal muscle
and BAT, are just very low, as alluded to by Cadenas
et al. [28] for UCP 2 and Matthias et al. [43] for UCP
2 and UCP 3 in BAT of UCP 1 ablated mice, re-
spectively.
5. Functional analyses of UCP 2 and 3 in cells and
mitochondria
Due to the possible uncoupling nature of these
novel uncoupling proteins, functional studies have
tended to focus on whether resting cellular/state
4 mitochondrial oxygen consumption rates increased
and/or resting cellular membrane potentials de-
creased as a result of varying the expression of
UCP 2 and UCP 3. Decreases in resting in situ mi-
tochondrial membrane potentials alone, measured
using £uorescent probe detection systems and UCP
2 or UCP 3 expression systems, have been taken as
evidence of the uncoupling e¡ect and by default the
mitochondrial location of UCP 2 and UCP 3. How-
ever, concomitant measurement of an increase in
resting oxygen consumption is required to add cred-
ibility to such an interpretation as inhibition of sub-
strate supply to in situ mitochondria could also de-
crease resting membrane potential.
Diminished resting membrane potentials in yeast
[36,37,44^46] are reported when these cells are trans-
fected with novel UCPs. Resting mitochondrial
membrane potential has also been shown to be di-
minished in the breast cancer cell line MCF7 trans-
fected with UCP 3 [47] and C2C12 myotubules (mod-
estly diminished) [5] transfected with UCP 3.
Increased oxygen consumption has been seen in mi-
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tochondria from the yeast transfected with UCP3L
and UCP3s [45]. Expression of the oxoglutarate car-
rier in the same yeast had no e¡ect on oxygen con-
sumption rate or resting membrane potential [48].
Hinz et al. [44] also see increases in whole yeast oxy-
gen consumption and heat production in UCP3L
transfected yeast cells. Rial et al. [49] also demon-
strate that state 4 rates are increased in mitochondria
isolated from yeast cells expressing UCP 1, UCP 2
and UCP 3. There are also unpublished data, re-
ported in Ricquier and Bouillaud [6], which show
increased oxygen consumption rate, compared with
controls, at any selected membrane potential, in
spheroplasts of yeast expressing UCP 2 (F. Bouillaud
and M. Goubern, unpublished data). Direct regula-
tion of novel UCP function has also been investi-
gated. Data in the literature show that mitochondrial
oxygen consumption from UCP 2 transfected yeast is
insensitive to addition of fatty acids and purine nu-
cleotides but increased on addition of retinoic acid
[49]. Oxygen consumption by UCP 3 transfected
yeast is insensitive to addition of free fatty acids,
purine nucleotides or retinoic acid [45,49,50]. Retino-
ic acid would therefore appear to be a putative ‘acti-
vator’ of UCP 2 function.
An interesting con£ict of function comes from mu-
tagenesis studies on UCP 1. Bienebraeger et al. [51]
have shown that the histidine pair (H145 and H147)
is essential for proton translocation. They conclude
that because UCP 2 and UCP 3 lack the histidine
pair, they cannot function as proton translocators.
Similar mutagenesis studies in the yeast expression
system would seem to con£ict with this observation
[48].
Indications and context of function also come
from mRNA expression studies. Northern blot anal-
yses have shown that there are a wide variety of
hormones, hormone agonists and physiological con-
ditions that in£uence UCP 2 and UCP 3 mRNA
expression both using in vivo (whole animal) and
in vitro (cell) systems (see reviews [6,7,52]). UCP 2
expression is increased by factors that a¡ect energy
metabolism such as thyroid status, leptin status, star-
vation, and pyrogenic elements. UCP 3 expression is
also a¡ected by factors that a¡ect energy metabolism
in particular factors that increase fatty mobilisation
and oxidation. As examples, UCP 3 mRNA expres-
sion in rat skeletal muscle is increased by starvation
(10-fold in soleus) [38], chronic exercise (15-fold;
non-discriminate muscle) [53] and T3 administration
[12] (5-fold). Parallel increases in UCP 3 protein were
not reported in the aforementioned. UCP 2 message
is increased 14-fold in BAT of UCP 1 ablated mice
[43] compared to wild-type, 5-fold in skeletal muscle
(non-discriminate muscle) [28] of starved animals
compared to controls and 28-fold in liver of lipo-
polysaccharide treated rats [54]. Matthias et al. [43]
and Cadenas et al. [28] could not detect any UCP 2
protein increases to correspond to these mRNA
changes. No reported attempts to measure UCP 2
protein have been recorded in the case of lipopoly-
saccharide administration.
Detection and quanti¢cation of protein changes
are central to predicting function in non-transfected
expression systems. Large changes in mRNA levels,
such as the aforementioned, are the most promising
experimental regimes when looking for changes in
protein expression. To that end, Cadenas et al. [28]
have demonstrated that UCP 3 mRNA level in skel-
etal muscle increased 4-fold (non-discriminate
muscle) which manifest itself as a 2-fold increase in
UCP 3 protein. When proton leak rate was mea-
sured, in the presence of defatted BSA (to mop
up free fatty acids), no di¡erence was observed be-
tween the leak rates in skeletal muscle mitochondria
from starved rats when compared to mitochondria
from unstarved animals. The authors conclude that
UCP 3 does not catalyse the basal conductance in
skeletal muscle mitochondria. Interestingly, skeletal
muscle mitochondria isolated from UCP 3 ablated
mice have decreased state 4/proton leak rates
[55,56], whilst mitochondria from mice overexpress-
ing UCP have increased state 4 oxygen consump-
tion [57].
6. Reconstituted UCP 2 and UCP 3
Expressed UCP 2 and UCP 3 have been reconsti-
tuted in proteoliposomes and proton and chloride
transport studies undertaken. Echtay et al. [58] ex-
pressed UCP 1 and UCP 3 in E. coli and reconsti-
tuted into liposomes. Chloride £ux was measured
and was shown to be inhibited by exogenous submi-
cromolar GDP/GTP concentrations. Unlike in native
UCP 1 reconstituted systems, proton £ux in the
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E. coli expressed UCP 1-reconstituted system could
not be detected even upon edition of 125 WM laurate.
Jaburek et al. [59] expressed UCP 1 in yeast and
UCP 2 and UCP 3 in E. coli. The solubilised pro-
teins were reconstituted into liposomes. Chloride
£ux was not measured but proton £ux was detected,
and dependent on fatty acid (40 WM palmitate)
and was shown to be moderately GDP sensitive.
Taken together, the results suggest an uncoupling
function for UCP 2 and UCP 3 similar to that of
UCP 1.
7. Transgenic mice
Recent studies on transgenic animals have been
interesting. Mice in which UCP 3 has been ablated
lacked obvious phenotypes (e.g. no e¡ects on body
mass and metabolic rate) [55,56]. However mice
overexpressing human UCP 3 are hyperphagic and
are leaner than their wild-type counterparts [57], a
phenotype consistent with an uncoupling e¡ect on
mitochondria.
8. Conclusion
Quantitatively proton leak contributes to V25%
of the resting oxygen consumption of mammals. Pro-
ton leak is also a determinant in accounting for dif-
ferences in basal metabolic rate. The mechanism of
the proton leak is unclear, but the data in the liter-
ature suggest that a di¡usion-mediated basal proton
leak occurs across mitochondria. The high degree of
sequence homology of the recently cloned uncou-
pling proteins UCP 2 and UCP 3 to brown adipose
tissue UCP 1, and the extensive tissue distribution,
suggest that they play a role in proton leak. The
expression patterns and the phenotype of the mice
overexpressing UCP 3 suggest that the novel uncou-
pling proteins UCP 2 and UCP 3 are important de-
terminants of basal metabolism. In vitro and recon-
stitution experiments strongly suggest that the novel
uncoupling proteins uncouple mitochondria, an ef-
fect that is probably superimposed upon the basal
proton leak that occurs in all mitochondria investi-
gated.
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